Inventor
EMILY ARNSDORF
Inventor
US
Overview
Patents· 3 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes33%
A61NElectrotherapy33%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations33%
PatentTitleYear
12,403,308Swallowable capsule and method for stimulating incretin production within the intestinal tract202511,872,396Swallowable capsule and method for stimulating incretin production within the intestinal tract202411,439,817Swallowable capsule and method for stimulating incretin production within the intestinal tract2022Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2022–2025Patents assigned to INCUBE LABS LLC (3)· patent assignee history
2022–2025Based in US· patent location history
2025Patents assigned to ALVA THERAPEUTICS INC (1)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| INCUBE LABS LLC | 3 | 2022–2025 |
| ALVA THERAPEUTICS INC | 1 | 2025 |
Locations
| Location | Patents | Span |
|---|---|---|
| US | 3 | 2022–2025 |